Tissue management in precision medicine: What the pathologist needs to know in the molecular era

Autores da FMUP
Participantes de fora da FMUP
- da Silva, RS
- Pinto, R
- Cirnes, L
Unidades de investigação
Abstract
Precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. " Among many medical specialists involved in precision medicine, the pathologists play an important and key role in the implementation and development of molecular tests that are in the center of decision of many therapeutic choices. Besides many laboratory procedures directly involved in the molecular tests, is fundamental to guarantee that tissues and cells collected for analysis be managed correctly before the DNA/RNA extraction. In this paper we explore the pivotal and interconnected points that can influence molecular studies, such as pre-analytical issues (fixation and decalcification); diagnosis and material selection, including the calculation of nuclei neoplastic fraction. The standardization of sample processing and morphological control ensures the accuracy of the diagnosis. Tissue or cytological samples constitutes the main foundation for the determination of biomarkers and development of druggable targets. Pathology and precision oncology still have a long way to go in terms of research and clinical practice: improving the accuracy and dissemination of molecular tests, learning in molecular tumor boards for advanced disease, and knowledge about early disease. Precision medicine needs pathology to be precise.
Copyright © 2022 Souza da Silva, Pinto, Cirnes and Schmitt.
Dados da publicação
- ISSN/ISSNe:
- 2296-889X, 2296-889X
- Tipo:
- Review
- Páginas:
- 983102-983102
- Link para outro recurso:
- www.scopus.com
Frontiers in Molecular Biosciences Frontiers Media S.A.
Citações Recebidas na Web of Science: 1
Citações Recebidas na Scopus: 5
Documentos
- Não há documentos
Filiações
Keywords
- molecular pathology; morphological control; oncology precision; personalized medicine; tissue management; solid tumors
Proyectos asociados
Parâmetros que demonstram ter influência na resposta à terapia neoadjuvante em pacientes com cancro da mama: Estado da arte e perspetivas futuras
Investigador Principal: Fernando Carlos de Landér Schmitt
Estudo Clínico Académico . 2021
Citar a publicação
da RS,Pinto R,Cirnes L,Schmitt F. Tissue management in precision medicine: What the pathologist needs to know in the molecular era. Front. Mol. Biosci. 2022. 9p. 983102-983102. IF:5,000. (2).